Lorazepam Injection, Solution
NDC Package 0409-1985-30
Package Information
Lorazepam injection is a medication used to treat anxiety. This formulation utilizes a injection, solution delivery system. Marketed by Hospira, Inc., this product is identified by NDC 0409-1985 and is authorized under FDA application ANDA074243.
Identification & Billing
- RxCUI: 763028 - LORazepam 2 MG in 1 ML Cartridge
- RxCUI: 763028 - 1 ML lorazepam 2 MG/ML Cartridge
- RxCUI: 763028 - lorazepam 2 MG per 1 ML Cartridge
- RxCUI: 763029 - LORazepam 4 MG in 1 ML Cartridge
- RxCUI: 763029 - 1 ML lorazepam 4 MG/ML Cartridge
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 0409 - Hospira, Inc.
- 0409-1985 - Lorazepam
- 0409-1985-30 - 10 CARTRIDGE in 1 CARTON / 1 mL in 1 CARTRIDGE (0409-1985-03)
- 0409-1985 - Lorazepam
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0409-1985). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0409-1985-30 identifies a specific commercial package of 10 cartridge in 1 carton / 1 ml in 1 cartridge (0409-1985-03) of Lorazepam, a human prescription drug labeled by Hospira, Inc.. This injection, solution is formulated for intramuscular; intravenous use and contains lorazepam as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hospira, Inc. on June 06, 2005. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat anxiety. Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA).
How is this Hospira, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00409198530. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.
